Literature DB >> 1388968

Prevalence of left ventricular hypertrophy and cardiac arrhythmias in borderline hypertension.

D Melina1, F Colivicchi, G Guerrera, G Melina, A Frustaci, M Caldarulo, C Guerrera.   

Abstract

Seventy-eight men with borderline hypertension according to the World Health Organization criteria underwent echocardiographic examination, followed by simultaneous ambulatory blood pressure and electrocardiographic monitorings for 24 h. The prevalence of echocardiographic left ventricular hypertrophy was 16.6% (13/78). Borderline hypertensives with left ventricular hypertrophy had more supraventricular (P less than .001) and ventricular ectopic beats (P less than .001) than normotensive controls and borderline hypertensives without cardiac involvement. Furthermore, ventricular ectopic activity was significantly related to left ventricular mass (r = 0.58, P less than .05) in borderline hypertensives showing echocardiographic evidence of left ventricular hypertrophy. Our findings suggest that noninvasive assessment of target organ status, including echocardiography, should be employed to optimize risk stratification in borderline hypertension.

Entities:  

Mesh:

Year:  1992        PMID: 1388968     DOI: 10.1093/ajh/5.8.570

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  3 in total

1.  Alterations of left ventricular function in women with insulin-dependent diabetes mellitus during pregnancy.

Authors:  C M Schannwell; M Schneppenheim; S M Perings; T Zimmermann; G Plehn; B E Strauer
Journal:  Diabetologia       Date:  2003-02-14       Impact factor: 10.122

Review 2.  Significance of left ventricular hypertrophy in cardiovascular morbidity and mortality.

Authors:  E Kaplinsky
Journal:  Cardiovasc Drugs Ther       Date:  1994-08       Impact factor: 3.727

3.  Prevalence of prehypertension and its relationship to risk factors for cardiovascular disease in Jamaica: analysis from a cross-sectional survey.

Authors:  Trevor S Ferguson; Novie O M Younger; Marshall K Tulloch-Reid; Marilyn B Lawrence Wright; Elizabeth M Ward; Deanna E Ashley; Rainford J Wilks
Journal:  BMC Cardiovasc Disord       Date:  2008-08-28       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.